<DOC>
	<DOCNO>NCT01332162</DOCNO>
	<brief_summary>The purpose study evaluate benefit optimal pacing configuration , include possibility biventricular leave ventricular pacing , hypertrophic obstructive cardiomyopathy patient .</brief_summary>
	<brief_title>CArdiac Desynchronization In Obstructive HCM , CARDIO-HCM</brief_title>
	<detailed_description>In study , subject randomize Cardiac Resynchronization Therapy-Defibrillation ( CRT-D ) Cardiac Resynchronization Therapy-Pacing ( CRT-P ) v Pacing Therapy AAI . Randomization stratify indication . Optimal pharmacological therapy treatment arm . Length follow-up subject 2y , since subject follow common study termination date .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Patients hypertrophic Obstructive Cardiomyopathy significant leave ventricular obstruction ( baseline LVOT gradient 50mmHg severe symptom HOCM intraventricular gradient &lt; 50mmHg LV ejection fraction &lt; 50 % mild symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hypertrophic Obstructive Cardiomyopathy ( HOCM )</keyword>
	<keyword>Pacing</keyword>
</DOC>